Goodwin Charles D. II 4
4 · Apyx Medical Corp · Filed Aug 31, 2022
Insider Transaction Report
Form 4
Goodwin Charles D. II
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-08-29$5.93/sh+2,000$11,860→ 30,250 total - Purchase
Common Stock
2022-08-29$5.97/sh+9,750$58,208→ 40,000 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $5.92 to $5.93. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.90 to $5.99. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.